Aurinia Pharmaceuticals Inc earned $2.07 per diluted share in fiscal year 2025. This represents an increase of 5075.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $2.29 per diluted share. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Aurinia Pharmaceuticals Inc has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Aurinia Pharmaceuticals Inc earned $2.07 per diluted share in fiscal year 2025.
Aurinia Pharmaceuticals Inc (AUPH) diluted earnings per share rose by 5075.0% year over year, from $0.04 to $2.07 in fiscal year 2025.
Aurinia Pharmaceuticals Inc (AUPH) reported $2.29 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 8 fiscal years this page covers, Aurinia Pharmaceuticals Inc (AUPH) diluted earnings per share went from -$0.63 in fiscal year 2018 to $2.07 in fiscal year 2025.
Aurinia Pharmaceuticals Inc (AUPH) reported $0.23 in diluted earnings per share in Q3 2026. That is unchanged from the same quarter a year earlier.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Aurinia Pharmaceuticals Inc (AUPH) reported on that line in every period on record.